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Abstract—Alkylation of (1-aryl-4-chloro-1H-imidazol-5-yl)methanethiols with alkyl halides, propargyl 
bromide, or chloroacetic acid gave 1-aryl-5-(R-sulfanylmethyl)-4-chloro-1H-imidazoles. 1-Aryl-4-chloro-5-
(methylsulfanylmethyl)-1H-imidazoles and [(1-aryl-4-chloro-1H-imidazol-5-yl)methylsulfanyl]acetic acids 
were oxidized to the corresponding sulfones with potassium permanganate.  
* For communication VII, see [1]. 
1H-Imidazol-5-ylmethylsulfanyl group and its  
S-oxidized derivatives are pharmacophores which are 
used in the design of biologically active compounds. In 
particular, it was used to modify pyrimidine structures 
possessing anti-inflammatory, analgesic, and antiepi-
leptic activity [2], N-aryl ureas exhibiting anti-athero-
sclerotic properties [3], and cephalosporins with pro-
nounced bactericidal effect [4]. 1H-Imidazol-5-yl-
methylsulfinate and -sulfonate fragments turned out to 
be quite valuable for the design of anti-HIV agents in 
the series of benzoazepines [5] and benzoazocines [6]. 
Taking into account the above stated, as well as the 
effect of substituents in the ring (e.g., of a chlorine 
atom in position 4) [7–10] on the biological properties 
of imidazole derivatives, we focused on an important 
synthetic problem, search for approaches to new 
sulfur-containing imidazole derivatives. It seemed 
reasonable to start the study with the development of  
a procedure for the synthesis of 5-(R-sulfanylmethyl)-
1-aryl-4-chloro-1H-imidazoles. 
In the preceding communication [1] we reported on 
the reaction of 4-chloro-5-chloromethyl-1H-imidazole 
with benzenethiols and hetarene-2-thiols, which af-
forded the corresponding aryl(or hetaryl)sulfanyl-
methyl-substituted imidazoles. However, the use of en-
vironmentally unsafe thiols involves some experimen-
tal difficulties and is not always justified. Therefore, 
we now propose a different procedure for the synthesis 
of 5-(alkylsulfanylmethyl)-1H-imidazoles, which is 
based on the alkylation of (1-aryl-4-chloro-1H-imid-
azol-5-yl)methanethiol with alkyl halides. 
For this purpose, initial 1-aryl-4-chloro-5-chloro-
methyl-1H-imidazoles Ia–Ic [1] were brought into 
reaction with thiourea in boiling dioxane. We thus 
obtained 80–89% of thiuronium salts IIa–IIc whose 
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I–III, Ar = 4-FC6H4 (a), 4-ClC6H4 (b), 4-MeC6H4 (c); IV, R = Me, Ar = 4-FC6H4 (a), 4-ClC6H4 (b), 4-MeC6H4 (c);  
R = Bu, Ar = 4-ClC6H4 (d); R = PhCH2, Ar = 4-ClC6H4 (e), 4-MeC6H4 (f). 
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hydrolysis with an alcoholic solution of sodium hy-
droxide at room temperature gave (1-aryl-1H-imid-
azol-5-yl)methanethiols IIIa–IIIc. The latter were 
isolated as solids having almost no mercaptan odor. 
Treatment of IIIa–IIIc in alcoholic solution with 
methyl iodide in the presence of sodium hydroxide 
afforded 80–86% of S-methyl derivatives IVa–IVc 
(method a). Compounds IVa–IVc can also be obtained 
in approximately the same yields by methylation of 
thiols IIIa–IIIc without their isolation from the reac-
tion mixture (method b). This one-pot procedure 
turned out to be convenient for the preparation of  
R-sulfanyl derivatives IVd–IVf by alkylation of thiols 
III with butyl bromide and benzyl chloride (Scheme 1). 
Taking into account synthetic importance of 
functionalized sulfanyl derivatives, we examined the 
alkylation of thiols IIIa–IIIc with propargyl bromide 
and chloroacetic acid. The reaction of IIIa–IIIc with 
propargyl bromide in alkaline medium at room tem-
perature afforded 1-aryl-5-[(prop-2-yn-1-ylsulfanyl)-
methyl]-1H-imidazoles Va–Vc, whereas in boiling 
ethanol isomeric 1-aryl-5-[(prop-1-ynylsulfanyl)-
methyl]-1H-imidazoles VIa–VIc were obtained 
(method a) as a result of base-catalyzed isomerization 
of primary alkylation products Va–Vc at elevated 
temperature. This is consistent with published data  
[11, 12], as well as with our results on the transforma-
tion of Vb into isomer VIb (method b). The alkylation 
of thiols IIIa–IIIc with chloroacetic acid under mild 
conditions led to the formation of [(1H-imidazol-5-
ylmethyl)sulfanyl]acetic acids VIIa–VIIc in high yield 
(Scheme 2). 
The presence of a chlorine atom in position 4 of the 
imidazole ring of compounds IV–VII essentially af-
fects the behavior of the sulfanylmethyl group toward 
oxidation. Unlike 4-unsubstituted analogs [3, 6], com-
pounds IV–VII are not oxidized to sulfinyl or sulfonyl 
derivatives with m-chloroperoxybenzoic acid or hydro-
gen peroxide. The use of such a strong oxidant as 
potassium permanganate turned out to be efficient for 
the oxidation of sulfides IVa–IVc, VIIa, and VIIb to 
sulfones VІІІa–VIIIe (Scheme 3). However, analo-
gous reaction with compounds Va and VIa gave 
complex oily mixtures of products, and we failed to 
isolate individual substances therefrom.  
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The structure of the synthesized compounds was 
confirmed by the IR, 1H and 13C NMR, and GC/MS 
data. Sulfanylmethylimidazoles IV–VII characteristi-
cally showed in the 1H NMR spectra singlets at δ 3.63–
4.00 ppm from methylene groups separating the imid-
azole ring and sulfur atom. In the spectra of VIIIa–
VIIId the corresponding signals were observed in  
a weaker field, at δ 4.29–4.53 ppm. The prop-2-yn-1-
ylsulfanyl fragment in Va–Vc gave rise to singletes at 
δ 3.11 (CH) and 3.22 ppm (CH2), while isomeric com-
pounds VIa–VIc displayed only a singlet at δ 1.81–
1.83 ppm from the terminal methyl group. 
EXPERIMENTAL 
The IR spectra were recorded in KBr on a UR-20 
spectrometer. The 1H and 13C NMR spectra were meas-
ured on a Bruker Avance DRX-500 spectrometer at 
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500.13 and 127.75 MHz, respectively, from solutions 
in DMSO-d6 using tetramethylsilane as internal refer-
ence. The mass spectra were obtained on an Aligent 
1100/DAD/HSD/ VLG119562 instrument. 
Compounds IIa–IIc (general procedure). Thio-
urea, 0.76 g (10 mmol), was added to a solution of  
10 mmol of 1-aryl-4-chloro-5-chloromethyl-1H-imid-
azole Ia–Ic in 20 mL of anhydrous dioxane. The mix-
ture was heated for 0.5 h under reflux and cooled, and 
the precipitate was filtered off and dried. 
[4-Chloro-1-(4-fluorophenyl)-1H-imidazol-5-yl]-
methyl carbamimidothioate hydrochloride (IIa). 
Yield 85%, mp 246–248°C. IR spectrum: ν 3360– 
3385 cm–1 (NH). 1H NMR spectrum, δ, ppm: 4.53 s 
(2H, CH2), 7.43–7.49 m (2H, Harom), 7.58–7.63 m (2H, 
Harom), 7.98 s (1H, 2-H), 9.35 br.s (4H, NH). Found, %: 
C 41.19;  H 3.50;  N 17.61.  m /z  322 [M  + 1]+. 
C11H10ClFN4S · HCl. Calculated, %: C 41.07; H 3.42; 
N 17.44. M 321.24. 
 [4-Chloro-1-(4-chlorophenyl)-1H-imidazol-5-yl]-
methyl carbamimidothioate hydrochloride (IIb). 
Yield 80%, mp 215–217°C. IR spectrum: ν 3360– 
3380 cm–1 (NH). 1H NMR spectrum, δ, ppm: 4.57 s 
(2H, CH2), 7.59 d (2H, Harom, J = 8.4 Hz), 7.67 d (2H, 
Harom, J = 8.4 Hz), 7.80 s (1H, 2-H), 9.39 br.s (4H, 
NH). Found, %: C 39.20; H 3.15; N 16.44. m/z 338  
[M + 1]+. C11H10Cl2N4S · HCl. Calculated, %: C 39.12; 
H 3.25; N 16.59. M 337.70. 
[4-Chloro-1-(4-methylphenyl)-1H-imidazol-5-yl]-
methyl carbamimidothioate hydrochloride (IIc). 
Yield 89%, mp 205–207°C. IR spectrum: ν 3365– 
3380 cm–1 (NH). 1H NMR spectrum, δ, ppm: 2.40 s 
(3H, CH3), 4.51 s (2H, CH2), 7.40 s (4H, Harom), 7.94 s 
(1H, 2-H), 9.35 br.s (4H, NH). Found, %: C 45.29;  
H 3.98; N 17.77. m/z 318. [M + 1]+. C12H13ClN4S · HCl. 
Calculated, %: C 45.42; H 4.09; N 17.65. M 317.28. 
Compounds IIIa–IIIc (general procedure). Sodi-
um hydroxide, 0.4 g (10 mmol), was added to a solu-
tion of 5 mmol of thiuronium salt IIa–IIc in 20 mL of 
ethanol, and the mixture was stirred for 1 h at room 
temperature. The mixture was poured into 50 mL of 
water and acidified to pH 4–5 with dilute hydrochloric 
acid, and the precipitate was filtered off, washed with 
water (3 × 20 mL), dried, and recrystallized from 70% 
aqueous ethanol. 
[4-Chloro-1-(4-fluorophenyl)-1H-imidazol-5-yl]-
methanethiol (IIIa). Yield 85%, mp 65–66°C. IR 
spectrum: ν 2565 cm–1 (SH). 1H NMR spectrum, δ, 
ppm: 2.83 t (1H, SH, J = 6.8 Hz), 3.68 d (2H, CH2, J = 
6.8 Hz), 7.39–7.65 m (4H, Harom), 7.85 s (1H, 2-H). 
Found, %: C 49.69; H 3.24; N 11.44. m/z 243 [M + 1]+. 
C10H8ClFN2S. Calculated, %: C 49.49; H 3.32;  
N 11.54. M 242.70. 
[4-Chloro-1-(4-chlorophenyl)-1H-imidazol-5-yl]-
methanethiol (IIIb). Yield 83%, mp 99–100°C. IR 
spectrum: ν 2260 cm–1 (SH). 1H NMR spectrum, δ, 
ppm: 2.85 t (1H, SH, J = 6.6 Hz), 3.82 t (2H, CH2, J = 
6.6 Hz), 7.50 d (2H, Harom, J = 8.4 Hz), 7.65 d (2H, 
Harom, J = 8.4 Hz), 7.87 s (1H, 2-H). Found, %:  
C 45.09;  H 3.03;  N 11.01.  m /z  260 [M  +  1]+. 
C10H8Cl2N2S. Calculated, %: C 46.35; H 3.11;  
N 10.81. M 259.16. 
[4-Chloro-1-(4-methylphenyl)-1H-imidazol-5-yl]-
methanethiol (IIIc). Yield 83%, mp 69–70°C. IR 
spectrum: ν 2265 cm–1 (SH). 1H NMR spectrum, δ, 
ppm: 2.38 s (3H, CH3), 2.78 t (1H, SH, J = 6.8 Hz), 
3.66 d (2H, CH2, J = 6.8 Hz), 7.33–7.39 m (4H, Harom), 
7.83 s (1H, 2-H). Found, %: C 55.12; H 4.70; N 11.90. 
m/z 239 [M + 1]+. C11H11ClN2S. Calculated, %:  
C 55.34; H 4.64; N 11.73. M 238.74. 
Compounds IVa–IVc (general procedure).  
a. Thiol IIIa–IIIc, 3 mmol, was dissolved in 15 mL of 
ethanol, 0.24 g (6 mmol) of sodium hydroxide and 
0.43 g (3 mmol) of methyl iodide were added in 
succession, and the mixture was stirred for 2 h and 
poured into 20 mL of water. The precipitate was 
filtered off, washed with water, dried, and recrystal-
lized from 70% aqueous ethanol. 
b. Sodium hydroxide, 0.36 g (9 mmol), was added 
to a solution of 3 mmol of thiuronium salt IIa–IIc in 
20 mL of ethanol, the mixture was stirred for 1 h,  
0.43 g (3 mmol) of methyl iodide was added, and the 
mixture was stirred for 2 h and poured into 30 mL of 
water. The precipitate was filtered off, washed with 
water, dried, and recrystallized from 70% aqueous 
ethanol. 
4-Chloro-1-(4-fluorophenyl)-5-[(methylsulfanyl)-
methyl]-1H-imidazole (IVa). Yield 83 (a), 86% (b), 
mp 86–87°C. 1H NMR spectrum, δ, ppm: 1.91 s (3H, 
CH3), 3.68 s (2H, CH2), 7.40–7.46 m (2H, Harom), 
7.59–7.64 m (2H, Harom), 7.87 s (1H, 2-H). Found, %: 
C 51.19;  H 3.84;  N 11.14.  m /z  257 [M  + 1]+. 
C11H10ClFN2S. Calculated, %: C 51.46; H 3.93;  
N 10.91. M 256.73. 
4-Chloro-1-(4-chlorophenyl)-5-[(methylsulfanyl)-
methyl]-1H-imidazole (IVb). Yield 85 (a), 86% (b), 
mp 109–110°C. 1H NMR spectrum, δ, ppm: 1.91 s 
(3H, CH3), 3.71 s (2H, CH2), 7.40 d (2H, Harom, J =  
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8.8 Hz), 7.64 d (2H, Harom, J = 8.8 Hz), 7.91 s (1H,  
2-H). Found, %: C 48.49; H 3.74; N 10.34. m/z 274  
[M + 1]+. C11H10Cl2N2S. Calculated, %: C 48.36;  
H 3.69; N 10.25. M 273.19. 
4-Chloro-1-(4-methylphenyl)-5-[(methylsul-
fanyl)methyl]-1H-imidazole (IVc). Yield 80 (a), 83% 
(b), mp 101–102°C. 1H, δ, ppm: 1.93 s (3H, CH3),  
2.38 s (3H, CH3), 3.65 s (2H, CH2), 7.36 d (2H, Harom, 
J = 8.0 Hz), 7.40 d (2H, Harom, J = 8.0 Hz), 7.82 s (1H, 
2-H). Found, %: C 57.19; H 5.09; N 10.94. m/z 253  
[M + 1]+. C12H13ClN2S. Calculated, %: C 57.02;  
H 5.18; N 11.08. M 252.77. 
Compounds IVd–IVf, Va–Vc, and VIIa–VIIc were 
synthesized in a similar way (method b). 
5-[(Butylsulfanyl)methyl]-4-chloro-1-(4-chloro-
phenyl)-1H-imidazole (IVd). Yield 80%, mp 54– 
55°C. 1H NMR spectrum, δ, ppm: 0.81 t (3H, CH3, J = 
8.4 Hz), 1.35–1.43 m (2H, CH2), 2.39 t (2H, CH2, J = 
8.0 Hz), 3.72 s (2H, CH2), 7.58 d (2H, Harom, J =  
8.8 Hz), 7.65 d (2H, Harom, J = 8.8 Hz), 7.89 s (1H,  
2-H). Found, %: C 53.49; H 5.21; N 9.02. m/z 316  
[M + 1]+. C14H16Cl2N2S. Calculated, %: C 53.34;  
H 5.12; N 8.89. M 315.27. 
5-[(Benzylsulfanyl)methyl]-4-chloro-1-(4-chloro-
phenyl)-1H-imidazole (IVe). Yield 86%, mp 77– 
78°C. 1H NMR spectrum, δ, ppm: 3.63 s (2H, CH2), 
3.66 s (2H, CH2), 7.15–7.29 m (5H, Harom), 7.49 d (2H, 
Harom, J = 8.4 Hz), 7.56 d (2H, Harom, J = 8.4 Hz),  
7.87 s (1H, 2-H). Found, %: C 58.69; H 4.14; N 7.84. 
m/z 350 [M + 1]+. C17H14Cl2N2S. Calculated, %:  
C 58.46; H 4.04; N 8.02. M 349.28. 
5-[(Benzylsulfanyl)methyl]-4-chloro-1-(4-methyl-
phenyl)-1H-imidazole (IVf). Yield 84%, mp 60– 
61°C. 1H NMR spectrum, δ, ppm: 2.38 (3H, CH3), 
3.63 s (2H, CH2), 3.65 s (2H, CH2), 7.15–7.39 m (9H, 
Harom), 7.81 s (1H, 2-H). Found, %: C 65.49; H 5.14;  
N 8.34. m/z 329 [M + 1]+. C18H17ClN2S. Calculated, 
%: C 65.74; H 5.21; N 8.52. M 328.87. 
4-Chloro-1-(4-fluorophenyl)-5-[(prop-2-yn-1-yl-
sulfanyl)methyl]-1H-imidazole (Va). Yield 82%,  
mp 69–70°C. 1H NMR spectrum, δ, ppm: 3.11 s (1H, 
HC≡), 3.22 s (2H, CH2C≡), 3.86 s (2H, CH2), 7.38–
7.62 m (4H, Harom), 7.87 s (1H, 2-H). 13C NMR spec-
trum, δC, ppm: 18.75 (CH2), 22.78 (CH2C≡), 73.56 
(≡CH), 79.96 (CH2C≡), 116.48 d (C3′, 2JCF = 23.8 Hz), 
122.92, 128.03 (Carom), 128.33 (C5), 131.87 (C4), 
136.86 (C2), 161.92 d (C4′, 1JCF = 248.6 Hz). Found, 
%: C 55.89; H 3.68; N 10.14. m/z 281 [M + 1]+. 
C13H10ClFN2S. Calculated, %: C 55.62; H 3.59;  
N 9.98. M 280.75. 
4-Chloro-1-(4-chlorophenyl)-5-[(prop-2-yn-1-yl-
sulfanyl)methyl]-1H-imidazole (Vb). Yield 84%,  
mp 87–88°C. 1H NMR spectrum, δ, ppm: 3.11 s (1H, 
HC≡), 3.22 s (2H, CH2C≡), 3.88 s (2H, CH2), 7.58 d 
(2H, Harom, J = 8.4 Hz), 7.64 d (2H, Harom, J = 8.4 Hz), 
7.89 s (1H, 2-H). 13C NMR spectrum, δC, ppm:  
18.36 (CH2), 23.13 (CH2C≡), 74.22 (≡CH), 80.17 
(CH2C≡), 123.43, 125.55, 129.66, 138.17 (Carom), 
128.62 (C5), 132.40 (C4), 136.14 (C2). Found, %:  
C  52 .79 ;  H  3 .34 ;  N  9 .34 .  m / z  298  [M  +  1 ]+. 
C13H10Cl2N2S. Calculated, %: C 52.54; H 3.39; N 9.43. 
M 297.21. 
4-Chloro-1-(4-methylphenyl)-5-[(prop-2-yn-1-yl-
sulfanyl)methyl]-1H-imidazole (Vc). Yield 84%,  
mp 75–76°C. 1H NMR spectrum, δ, ppm: 2.38 s (3H, 
CH3), 3.11 s (1H, HC≡), 3.22 s (2H, CH2C≡), 3.86 s 
(2H, CH2), 7.35 d (2H, Harom, J = 8.0 Hz), 7.44 d (2H. 
Harom, J = 8.0 Hz), 7.83 s (1H, 2-H). 13C NMR spec-
trum, δC, ppm: 18.82 (CH2), 20.45 (CH3), 22.89 
(CH2C≡), 73.37 (≡CH), 79.97 (CH2C≡), 122.79, 
125.27, 129.85, 138.55 (Carom), 128.21 (C5), 133.00 
(C4), 136.35 (C2). Found, %: C 60.42; H 4.62; N 10.24. 
m/z 277 [M + 1]+. C14H13ClN2S. Calculated, %:  
C 60.75; H 4.73; N 10.12. M 276.79. 
{[4-Chloro-1-(4-fluorophenyl)-1H-imidazol-5- 
yl]methyl}sulfanylacetic acid (VIIa). Yield 84%,  
mp 139–140°C. IR spectrum, ν, cm–1: 1685 (C=O), 
2430–2850 (OH). 1H NMR spectrum, δ, ppm: 3.17 s 
(2H, CH2), 3.82 s (2H, CH2), 7.36–7.43 m (2H, Harom), 
7.60–7.65 m (2H, Harom), 7.87 s (1H, 2-H), 12.55 br.s 
(1H, OH). Found, %: C 47.79; H 3.27; N 9.44. m/z 301 
[M + 1]+. C12H10ClFN2O2S. Calculated, %: C 47.93;  
H 3.35; N 9.31. M 300.74. 
{[4-Chloro-1-(4-chlorophenyl)-1H-imidazol-5- 
yl]methyl}sulfanylacetic acid (VIIb). Yield 85%,  
mp 86–87°C. IR spectrum, ν, cm–1: 1680 (C=O), 
2450–2840 (OH). 1H NMR spectrum, δ, ppm: 3.17 s 
(2H, CH2), 3.85 s (2H, CH2), 7.57–7.63 m (4H, Harom), 
7.90 s (1H, 2-H), 12.60 br.s (1H, OH). Found, %:  
C  45 .18 ;  H  3 .27 ;  N  8 .74 .  m / z  318  [M  +  1 ]+. 
C12H10Cl2N2O2S. Calculated, %: C 45.44; H 3.18;  
N 8.83. M 317.20. 
{[4-Chloro-1-(4-methylphenyl)-1H-imidazol- 
5-yl]methyl}sulfanylacetic acid (VIIc). Yield 82%,  
mp 111–113°C. IR spectrum, ν, cm–1: 1680 (C=O), 
2450–2820 (OH). 1H NMR spectrum, δ, ppm: 2.38 s 
(3H, CH3), 3.17 s (2H, CH2), 3.82 s (2H, CH2), 7.36 d 
(2H, Harom, J = 8.0 Hz), 7.41 d (2H, Harom, J = 8.0 Hz), 
7.83 s (1H, 2-H), 12.54 br.s (1H, OH). Found, %:  
C 52 .78 ;  H  4 .27 ;  N  9 .60 .  m / z  297  [M  +  1 ]+. 
C13H13ClN2O2S. Calculated, %: C 52.61; H 4.42;  
N 9.44. M 296.78. 
Compound VIa–VIc (general procedure). a. Sodi-
um hydroxide, 0.36 g (9 mmol), was added to a solu-
tion of 3 mmol of thiuronium salt IIa–IIc in 20 mL of 
ethanol, the mixture was stirred for 1 h, a solution of 
0.47 g (4 mmol) of propargyl bromide in 5 ml of 
ethanol was added, and the mixture was heated for  
0.5 h, cooled, and poured into 20 mL of water. The 
precipitate was filtered off, washed with water (3 × 
20 mL), dried, and recrystallized from 70% aqueous 
ethanol. 
b. Sodium hydroxide, 0.08 g (2 mmol), was added 
to a solution of 2 mmol of compound Vb in 10 mL of 
ethanol, the mixture was heated for 0.5 h under reflux, 
cooled, and poured into 10 mL of water. The precip-
itate was filtered off, washed with water (3 × 10 mL), 
dried, and recrystallized from 70% aqueous ethanol. 
4-Chloro-1-(4-fluorophenyl)-5-[(prop-1-yn-1-yl-
sulfanyl)methyl]-1H-imidazole (VIa). Yield 85% (a), 
mp 80–81°C. 1H NMR spectrum, δ, ppm: 1.83 s (3H, 
CH3), 3.97 s (2H, CH2), 7.40–7.63 m (4H, Harom),  
7.89 s (1H, 2-H). 13C NMR spectrum, δC, ppm: 4.38 
(CH3C≡), 27.08 (CH2), 65.66 (SC≡), 92.91 (≡SCH3), 
116.20 d (C3′, C5′, 2JCF = 25.3 Hz), 122.34 (Carom), 
128.01 d (C2′, C6′, 3JCF = 6.8 Hz), 129.33 (C5), 131.70 
(C4), 136.99 (C2), 161.93 d (C4′, 1JCF = 245.0 Hz). 
Found, %: C 55.84; H 3.49; N 9.84. m/z 281 [M + 1]+. 
C13H10ClFN2S. Calculated, %: C 55.62; H 3.59;  
N 9.98. M 280.75. 
4-Chloro-1-(4-chlorophenyl)-5-[(prop-1-yn-1-yl-
sulfanyl)methyl]-1H-imidazole (VIb). Yield 84 (a), 
78% (b), mp 85–86°C. 1H NMR spectrum, δ, ppm: 
1.81 s (3H, CH3), 4.00 s (2H, CH2), 7.55 d (2H, Harom, 
J = 8.4 Hz), 7.65 d (2H, Harom, J = 8.4 Hz), 7.93 s (1H, 
2-H). 13C NMR spectrum, δC, ppm: 4.41 (CH3C≡), 
27.03 (CH2), 65.57 (SC≡), 92.84 (≡CCH3), 122.15, 
127.59, 129.57, 134.18 (Carom), 129.54 (C5), 133.66 
(C4), 136.65 (C2). Found, %: C 52.79; H 3.34; N 9.34. 
m/z 298 [M + 1]+. C13H10Cl2N2S. Calculated, %:  
C 52.54; H 3.39; N 9.43. M 297.21. 
4-Chloro-1-(4-methylphenyl)-5-[(prop-1-yn-1-yl-
sulfanyl)methyl]-1H-imidazole (VIc). Yield 85% (a), 
mp 79–80°C. 1H NMR spectrum, δ, ppm: 1.82 s (3H, 
CH3), 2.38 s (3H, CH3), 3.97 s (2H, CH2), 7.38 s (4H, 
Harom), 7.86 s (1H, 2-H). 13C NMR spectrum, δC, ppm: 
4.31 (CH3C≡), 20.69 (CH3), 27.15 (CH2), 65.72 (SC≡), 
92.78 (≡CCH3), 122.03, 125.31, 129.84, 138.69 
(Carom), 129.25 (C5), 132.78 (C4), 136.72 (C2). Found, 
%: C 60.59; H 4.64; N 10.01. m/z 277 [M + 1]+. 
C14H13ClN2S. Calculated, %: C 60.75; H 4.73;  
N 10.12. M 276.79. 
Compounds VIIIa–VIIIe (general procedure). 
Potassium permanganate, 0.48 g (3 mmol), was added 
under stirring over a period of 0.5 h to a suspension of 
2 mmol of 5-[(R-sulfanyl)methyl]imidazole IVa–IVc, 
VIIa, or VIIb in 2 mL of water, and the mixture was 
stirred for 2 h. The mixture was then treated with solid 
sodium sulfite until violet color disappeared and ex-
tracted with benzene. The organic phase was dried 
over sodium sulfate and evaporated, and the residue 
was recrystallized from 70% aqueous ethanol. 
4-Chloro-1-(4-fluorophenyl)-5-[(methylsulfonyl)-
methyl]-1H-imidazole (VIIIa). Yield 50%, mp 129–
130°C. 1H NMR spectrum, δ, ppm: 2.93 s (3H, CH3), 
4.49 s (2H, CH2), 7.36–7.72 m (4H, Harom), 7.98 s (1H, 
2-H). Found, %: C 45.89; H 3.54; N 9.84. m/z 289  
[M + 1]+. C11H10ClFN2O2S. Calculated, %: C 45.76;  
H 3.49; N 9.70. M 288.73. 
4-Chloro-1-(4-chlorophenyl)-5-[(methylsulfonyl)-
methyl]-1H-imidazole (VIIIb). Yield 48%, mp 117–
119°C. 1H NMR spectrum, δ, ppm: 2.95 s (3H, CH3), 
4.53 s (2H, CH2), 7.56 d (2H, Harom, J = 8.4 Hz), 7.63 d 
(2H, Harom, J = 8.4 Hz), 8.01 s (1H, 2-H). Found, %:  
C  43 .49 ;  H  3 .40 ;  N  9 .04 .  m / z  306  [M  +  1 ]+. 
C11H10Cl2N2O2S. Calculated, %: C 43.29; H 3.30;  
N 9.18. M 305.18. 
4-Chloro-1-(4-methylphenyl)-5-[(methylsul-
fonyl)methyl]-1H-imidazole (VIIIc). Yield 45%,  
mp 115–117°C. 1H NMR spectrum, δ, ppm: 2.37 s 
(3H, CH3), 2.90 s (3H, CH3), 4.48 s (2H, CH2), 7.37 s 
(4H, Harom), 7.95 s (1H, 2-H). Found, %: C 50.49;  
H 4.49; N 9.94. m/z 285 [M + 1]+. C12H13ClN2O2S. 
Calculated, %: C 50.61; H 4.60; N 9.84. M 284.77. 
{[4-Chloro-1-(4-fluorophenyl)-1H-imidazol-5- 
yl]methylsulfonyl}acetic acid (VIIId). Yield 54%,  
mp 178–180°C. 1H NMR spectrum, δ, ppm: 4.29 s 
(2H, CH2), 4.71 s (2H, CH2), 7.37–7.58 m (4H, Harom), 
7.97 s (1H, 2-H), 13.48 br.s (1H, OH). Found, %:  
C  43 .59 ;  H  2 .97 ;  N  8 .54 .  m / z  333  [M  +  1 ]+. 
C12H10ClFN2O4S. Calculated, %: C 43.32; H 3.03;  
N 8.42. M 332.74. 
{[4-Chloro-1-(4-chlorophenyl)-1H-imidazol-5- 
yl]methylsulfonyl}acetic acid (VIIIe). Yield 55%,  
mp 208–210°C. IR spectrum, ν, cm–1: 1680 (C=O), 
2450–2840 (OH). 1H NMR spectrum, δ, ppm: 4.30 s 
(2H, CH2), 4.73 s (2H, CH2), 7.54 d (2H, Harom, J =  
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8.4 Hz), 7.61 d (2H, Harom, J = 8.4 Hz), 8.02 s (1H,  
2-H), 13.50 br.s (1H, OH). 13C NMR spectrum, δC, 
ppm: 47.50 (CH2), 57.36 (CH2), 114.69 (C5), 128.89, 
129.29, 133.77, 134.19 (Carom), 132.03 (C4), 135.42 
(C2), 164.37 (C=O). Found, %: C 41.48; H 2.77;  
N 7.90. m/z 350 [M + 1]+. C12H10Cl2N2O4S. Calculat-
ed, %: C 41.28; H 2.89; N 8.02. M 349.20. 
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